MannKind Corp Inventory Over Time
| MNKD Stock | USD 6.67 0.01 0.15% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out MannKind Corp Performance and MannKind Corp Correlation. MannKind |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MannKind Corp. If investors know MannKind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MannKind Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.246 | Earnings Share 0.08 | Revenue Per Share 0.982 | Quarterly Revenue Growth 0.367 | Return On Assets 0.0912 |
The market value of MannKind Corp is measured differently than its book value, which is the value of MannKind that is recorded on the company's balance sheet. Investors also form their own opinion of MannKind Corp's value that differs from its market value or its book value, called intrinsic value, which is MannKind Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MannKind Corp's market value can be influenced by many factors that don't directly affect MannKind Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MannKind Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if MannKind Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MannKind Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Inventory Analysis
Compare MannKind Corp and related stocks such as Biomarin Pharmaceutical, Vaxcyte, and Liquidia Technologies Inventory Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMRN | 100 K | 130.1 M | 128.7 M | 162.6 M | 199.5 M | 271.7 M | 355.1 M | 475.8 M | 530.9 M | 680.3 M | 698.5 M | 776.7 M | 894.1 M | 1.1 B | 1.2 B |
| PCVX | (200 K) | (200 K) | (200 K) | (200 K) | (200 K) | (200 K) | (200 K) | (200 K) | (200 K) | (200 K) | (300 K) | (1.2 M) | (1000 K) | (6.2 M) | (5.9 M) |
| LQDA | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | 0.8 |
| LEGN | 11 K | 11 K | 11 K | 11 K | 11 K | 11 K | 11 K | 11 K | 1.1 M | 1.2 M | 1.8 M | 1.7 M | 10.4 M | 19.4 M | 20.4 M |
| TECH | 1.6 M | 38.3 M | 34.9 M | 38.8 M | 49.6 M | 57.1 M | 60.2 M | 85.6 M | 91 M | 103.2 M | 116.7 M | 141.1 M | 171.6 M | 179.7 M | 188.7 M |
| UTHR | 2.9 M | 46 M | 37.3 M | 47.8 M | 66.9 M | 81.3 M | 100 M | 107.9 M | 101 M | 93.4 M | 86.5 M | 93.8 M | 102 M | 111.8 M | 55.9 M |
| LRMR | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 3.2 M | 3.2 M | 3.2 M | (32 K) | (208 K) | (208 K) | (187.2 K) | (177.8 K) |
| KNSA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.7 M | 21.6 M | 31.1 M | 32.7 M |
| VSTM | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (154 K) | 0.0 | 0.0 | 327 K | 3.1 M | 0.0 | (100.8 M) | (100.8 M) | (90.7 M) | (86.2 M) |
| IMMP | (22.5 K) | 191.7 K | 1.1 M | 1.1 M | 402 K | 591.9 K | 642 K | 1.0 | 1.0 | 1.0 | (5.7 M) | (1.1 M) | 2.0 | 1.9 M | 2 M |
| NRXPW | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | 214 K | (7 K) | (7 K) | (6 K) | (5.7 K) |
| KTTA | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | (40.5 K) | (38.5 K) |
| INKT | 87.7 K | 87.7 K | 87.7 K | 87.7 K | 87.7 K | 87.7 K | 87.7 K | 87.7 K | 87.7 K | 87.7 K | 1 M | 1.8 K | 1.8 K | 1.6 K | 1.5 K |
| AFMD | 121 K | 121 K | 121 K | 140 K | 199 K | 228 K | 197 K | 241 K | 260 K | 296 K | 246 K | 421 K | 628 K | 463 K | 315.3 K |
| ADAP | 102.2 K | 102.2 K | 102.2 K | 102.2 K | 102.2 K | 102.2 K | 1.2 M | 3.8 M | 1.1 M | 1.5 M | 2.1 M | 746 K | 1.3 M | 1.3 M | 1.4 M |
| SGMO | 0.0 | 0.0 | (12.5 M) | (38.2 M) | (46.7 M) | (307 K) | (224 K) | (1.3 M) | (375 K) | (22.5 M) | (50.5 M) | (88.2 M) | 1.0 | 0.9 | 0.95 |
MannKind Corp and related stocks such as Biomarin Pharmaceutical, Vaxcyte, and Liquidia Technologies Inventory description
My Equities
My Current Equities and Potential Positions
| MannKind Corp | MNKD |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 6.67
Check out MannKind Corp Performance and MannKind Corp Correlation. For information on how to trade MannKind Stock refer to our How to Trade MannKind Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
MannKind Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.